Shortfall in Phase-III Covaxin trial target, can delay rollout: AIIMS doctor
India | December 18, 2020 13:49 ISTThe rollout of Covid-19 vaccine by Bharat Biotech for the general public may get delayed as the All India Institute of Medical Sciences (AIIMS), where its Phase-III human clinical trial is underway, is struggling to find takers of the trial shots, the official heading the project told IANS.